At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7 enrolled
Drug / intervention
Holmium: YAG laserprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Minimally Invasive Holmium:YAG Laser Blepharoplasty
In Brief
A clinical study evaluating Holmium: YAG laser for Lower Eyelid Entropion. Completed, enrolled 7 participants across 1 site.
Detailed Summary
The purpose of this research study is to is to evaluate the safety and effectiveness of the FDA approved Holmium:YAG laser for reducing lower eyelid bags.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLower Eyelid Entropion
CountriesUnited States
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedFeb 2009
Primary CompletionSep 2014
TodayJul 2026
First PostedFeb 12, 2009
Enrollment StartJan 1, 2009
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 17.4 years ago
Interventions
Holmium: YAG laserprocedure
Minimally Invasive Holmium:YAG laser Blepharoplasty